ARTICLE | Financial News
D&D raises $137M to fund inflammation tech out of JHU
August 14, 2019 10:51 PM UTC
South Korea’s D&D Pharmatech raised $137.1 million in a series B round to push forward the pipelines of its trio of inflammation-focused subsidiaries.
Founded in 2014, D&D Pharmatech Co. Ltd. (Gyeonggi-do, South Korea) is the parent company of a series of wholly owned subsidiaries that house technology in-licensed from Johns Hopkins University...